tirzepatide dry mouth mouth: why it happens and how to fix it The Science Behind Tirzepatide Medical

Some people are naturally more sensitive to GLP-1 receptor agonism, experiencing stronger appetite suppression but also more intense gastrointestinal effects

However, the SURMOUNT-5 trial compared tirzepatide to semaglutide 2.4mg (a more potent GLP-1 agonist than liraglutide), and tirzepatide still showed superior weight loss: 20.2% vs 13.7% at 72 weeks

When side effects are a deterrent to taking Farxiga, stepping away from SGLT2 inhibitors could be considered

If you are using a lower dose, a vial will last longer

Or it could be that the drugs wont work well enough for these conditions

Antimicrobial Peptides: A Potent Alternative to Antibiotics